http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02188600-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
filingDate 1989-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_249d9c3256696679470c32c2be202e80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5063b3a6ebb87d3b221268c23bca70c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa9e880cbb1a9bb9812af2babab34129
publicationDate 1990-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02188600-A
titleOfInvention Bsf2 antagonist
abstract NEW MATERIAL:A polypeptide in which plurality of amino acids are lost from N ends and/or C ends of human B cell stimulation factor 2 expressed by the formula, etc., and having antagonism action to the human B cell stimulation factor 2. n USE: A remedy and diagnostic for artrial myxoma, carcinoma of uterine cervix, endotoxin, shock, myeloma, chronic rheumatism, etc. n PREPARATION: For example, a method for successively bonding amino acids whose α-amino groups are protected according to normal Merrifield solid method by BOC method so as to synthesize a peptide chain is used and proceeding of coupling of the protected amino acid is carried out using Kaiser test while monitoring to provide the polypeptide in which plurality of amino acids are lost from N ends and/or C ends of human B cell stimulation factor 2. n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4098279-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2898896-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9748728-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008037875-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007058194-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3640261-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3167901-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007086490-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1972638-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2298812-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019151418-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020213665-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007043641-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2368577-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3135298-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005037315-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007046489-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9835694-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3903819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7824674-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10519232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007116962-A1
priorityDate 1989-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10236

Total number of triples: 42.